Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840.
Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26520-26530. doi: 10.1073/pnas.2005237117. Epub 2020 Oct 5.
The human genome encodes for over 1,500 RNA-binding proteins (RBPs), which coordinate regulatory events on RNA transcripts. Most studies of RBPs have concentrated on their action on host protein-encoding mRNAs, which constitute a minority of the transcriptome. A widely neglected subset of our transcriptome derives from integrated retroviral elements, termed endogenous retroviruses (ERVs), that comprise ∼8% of the human genome. Some ERVs have been shown to be transcribed under physiological and pathological conditions, suggesting that sophisticated regulatory mechanisms to coordinate and prevent their ectopic expression exist. However, it is unknown how broadly RBPs and ERV transcripts directly interact to provide a posttranscriptional layer of regulation. Here, we implemented a computational pipeline to determine the correlation of expression between individual RBPs and ERVs from single-cell or bulk RNA-sequencing data. One of our top candidates for an RBP negatively regulating ERV expression was RNA-binding motif protein 4 (RBM4). We used photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation to demonstrate that RBM4 indeed bound ERV transcripts at CGG consensus elements. Loss of RBM4 resulted in an elevated transcript level of bound ERVs of the HERV-K and -H families, as well as increased expression of HERV-K envelope protein. We pinpointed RBM4 regulation of HERV-K to a CGG-containing element that is conserved in the LTRs of HERV-K-10, -K-11, and -K-20, and validated the functionality of this site using reporter assays. In summary, we systematically identified RBPs that may regulate ERV function and demonstrate a role for RBM4 in controlling ERV expression.
人类基因组编码了超过 1500 种 RNA 结合蛋白(RBPs),它们协调 RNA 转录本的调控事件。大多数关于 RBPs 的研究都集中在它们对宿主蛋白编码 mRNA 的作用上,而这些 mRNA 只构成转录组的一小部分。我们转录组中被广泛忽视的一部分来自整合的逆转录病毒元件,称为内源性逆转录病毒(ERVs),它们占人类基因组的约 8%。一些 ERV 在生理和病理条件下被证明可以转录,这表明存在协调和防止它们异位表达的复杂调控机制。然而,目前还不清楚 RBPs 和 ERV 转录本之间是如何直接相互作用,提供转录后调控的。在这里,我们实施了一个计算管道,以确定单个细胞或批量 RNA-seq 数据中个体 RBP 和 ERV 表达之间的相关性。我们的一个 RBP 候选物,即 RNA 结合基序蛋白 4(RBM4),被证明可以负调控 ERV 的表达。我们使用光活化核苷酸增强交联和免疫沉淀实验,证明了 RBM4 确实在 CGG 保守元件上结合 ERV 转录本。RBM4 的缺失导致 HERV-K 和 -H 家族的结合 ERV 转录本水平升高,以及 HERV-K 包膜蛋白的表达增加。我们将 RBM4 对 HERV-K 的调控定位到一个含有 CGG 的元件上,该元件在 HERV-K-10、-K-11 和 -K-20 的 LTR 中保守,并使用报告基因实验验证了该位点的功能。总之,我们系统地鉴定了可能调节 ERV 功能的 RBPs,并证明了 RBM4 在控制 ERV 表达中的作用。